| GSGRX | RMEBX | GSGRX / RMEBX | |
| Total Expense Ratio | 0.99 | 1.07 | 93% |
| Annual Report Gross Expense Ratio | 1.19 | 1.07 | 111% |
| Fund Existence | 33 years | 11 years | - |
| Gain YTD | 4.560 | 2.231 | 204% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 435M | 112B | 0% |
| Annual Yield % from dividends | 1.08 | 1.08 | 100% |
| Returns for 1 year | 3.72 | 7.30 | 51% |
| Returns for 3 years | 18.83 | 28.21 | 67% |
| Returns for 5 years | 26.94 | 43.15 | 62% |
| Returns for 10 years | 98.15 | 103.95 | 94% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRWRX | 26.88 | -0.01 | -0.04% |
| Transamerica International Equity R | |||
| KSOCX | 152.59 | -0.07 | -0.05% |
| Kinetics Small Cap Opportunities Adv C | |||
| RYOIX | 77.25 | -0.11 | -0.14% |
| Rydex Biotechnology Inv | |||
| NPFFX | 71.11 | -0.89 | -1.24% |
| American Funds New Perspective F1 | |||
| IALAX | 39.27 | -1.09 | -2.70% |
| Transamerica Capital Growth A | |||